Charleston Reporter

Congresswoman Nancy Mace has introduced the "Childhood Genital Mutilation Prevention Act," a bill aimed at stopping gender-related surgeries and treatments for minors. The legislation seeks to protect children from irreversible procedures that could have lasting impacts on their health and wellbeing.

“Our children are not guinea pigs in the radical left’s dangerous social experimentation,” said Congresswoman Mace. “Only 12–27% of children with gender dysphoria carry it into adulthood, yet irreversible therapies and surgeries are far too available in the U.S. The genital mutilation of young bodies under the guise of progressivism is sick and protecting our children means saying no to this lunacy.”

The proposed bill includes strict penalties for those who knowingly perform or attempt to perform gender-related medical treatments on minors, with potential fines and imprisonment for up to 10 years. It also amends the Social Security Act to prohibit Medicare from covering these treatments, emphasizing responsible healthcare practices.

Key provisions of the "Childhood Genital Mutilation Prevention Act" include:

- Banning any surgical or medical procedures related to gender transition for individuals under 18 and establishing new criminal statutes.

- Prohibiting federal funds from being used towards such treatments for children and from being used for any health benefits coverage that includes such treatments.

- Imposing significant penalties on healthcare providers who perform these treatments, including fines and potential imprisonment of up to 10 years.

- Amending the Social Security Act to prevent Medicare from funding gender-related treatments for minors.

- Mandating healthcare providers report any cases of gender-related medical treatments performed on minors to ensure accountability.

The legislation allows exceptions for necessary medical treatment related to specific disorders of sex development, ensuring genuine medical needs are addressed while protecting children from unnecessary risks.

For media inquiries, please contact SC01press@mail.house.gov